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vertebral fracture and pulmonary function in the
sixth Tromsø study
Bente Morseth1,2*, Hasse Melbye3, Svanhild Waterloo1, Marte R Thomassen1,4, Marijke J Risberg5 and Nina Emaus6Abstract
Background: Persons with vertebral fracture may have reduced pulmonary function, but this association has not
been much studied. The aim of this cross-sectional study was therefore to examine the relationship between
vertebral fracture and pulmonary function in a general, elderly population.
Methods: Vertebral morphometry was used for vertebral fracture assessment in 2132 elderly men (n = 892) and
women (n = 1240) aged 55 to 87 years in the population-based Tromsø Study 2007–08. Pulmonary function was
examined by spirometry. Pulmonary function was expressed as FVC% predicted, FEV1% predicted, and FEV1/FVC%
predicted values, adjusted FVC, FEV1, and FEV1/FVC, and obstructive and restrictive ventilatory impairment. Vertebral
fracture was classified according to appearance, number, severity, and location of fractures. Associations were
analyzed using general linear and logistic models.
Results: FVC% predicted and FEV1% predicted values were not associated with vertebral fracture (P > 0.05), whereas
FEV1/FVC% predicted ratio was associated with both prevalent fracture, number of fractures, severity of fractures,
and fracture site in men (P < 0.05), but not in women. When FVC, FEV1, and FEV1/FVC values were adjusted for
multiple covariates, we found no significant association with vertebral fracture. Obstructive and restrictive
ventilatory impairment was not associated with prevalent vertebral fracture.
Conclusions: In conclusion, this study did not confirm any clinically relevant associations between prevalent
vertebral fracture and ventilatory impairment in elderly individuals.
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Osteoporotic fractures represent a major health concern
among elderly people, and the highest incidences are
found in Scandinavia [1-5]. Much attention has been di-
rected toward the negative outcomes of hip fractures [6];
however, vertebral fractures are also associated with in-
creased morbidity [7] and mortality [8-10]. Progressive
collapse of the fractured vertebral body often results in
kyphosis, height loss, chronic pain, and possibly impaired
respiratory function [11,12]. Furthermore, vertebral frac-
tures are related to a high annual number of additional
vertebral fractures [13]. Previous patient-control data* Correspondence: bente.morseth@uit.no
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reproduction in any medium, provided the orprovide some evidence for an association between vertebral
fracture or other measures of kyphosis and pulmonary
function [11,14-17]. However, a recent systematic review in-
cluding four case–control studies concluded that although
patients with vertebral fracture demonstrate a modest re-
duction in pulmonary measures, evidence for an associ-
ation is limited [11]. The limited number of studies with
small sample sizes and predominantly female subjects call
for further research in this area. We therefore examined
whether presence of vertebral fracture was associated with
measures of pulmonary function in a larger, general popu-
lation of elderly men and women.l Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Design and subjects
The present study utilizes data from the 2007–08 Tromsø
Study (Tromsø 6). The Tromsø Study is a longitudinal,
population-based, multi-purposed health study with six
repeated surveys between 1974 and 2008, conducted in
the municipality of Tromsø, Northern Norway [18]. The
Tromsø 5 and 6 surveys were conducted in two phases,
with the most basic examination in phase 1 (height,
weight, blood pressure, blood samples, and question-
naires), followed by more extensive examinations for
random sub-samples of the cohort in phase 2 [19]. The
Tromsø Study was approved by the Norwegian Data
Inspectorate and the Regional Committee of Research
Ethics. All participants signed a written informed consent.
A total of 19 762 subjects were invited to participate
in Tromsø 6, and 12 984 (65.7%) of the invited subjects
attended Tromsø 6, phase 1. Among the participants
in phase 1, 11 484 subjects were invited to participate
in phase 2. Of the 7307 subjects attending Tromsø 6,
phase 2, only those with bone mineral density (BMD)
measurement from the previous Tromsø 5 (2001–02)
were invited for a dual X-ray (DXA) BMD measurement
of the hip, i.e. a dual femur scan (n = 3854). Among these,
lateral vertebral fracture assessment (VFA) was performed
in a randomly selected group (n = 2894). Seven blurred
VFA scans were excluded, leaving 2887 persons with valid
VFA measurements.
In the present study, we selected subjects aged ≥ 55 years
with valid measurements of vertebral fractures (n = 2478),
weight and height (n = 2221), and/or smoking habits
(n = 2178), which left 2176 subjects for analyses (Figure 1).
After exclusion of 13 (1.4%) men and 31 (2.4%) women
with inadequate spirometry, the study comprised 2132
subjects. For the multiple adjusted models, we further
excluded subjects with missing values for hip BMD
(n = 171), physical inactivity (n = 277), and/or hormone
drugs (n = 128 women), leaving 1674 persons (770 men
and 904 women) for inclusion in the adjusted model.
Assessment of pulmonary function
At the spirometry station in Tromsø 6, phase 2, recent
symptoms of common cold, bronchitis, or other airway
infections during the last 7 days were obtained through
a short questionnaire [20]. Immediately following, spir-
ometry was performed by trained technical staff with the
use of a “Sensor Medics Vmax Encore 20” spirometer,
following ATS/ERS criteria [21] with the subject seated.
The quality of the spirometry has been described previ-
ously [22], reporting that both inter- and intra-observer
agreements were close to optimal. Forced vital capacity
(FVC) and forced expiratory volume in one second (FEV1)
were measured with the subject performing a maximum
inspiration followed by a complete forceful expiration.Ascertainment of vertebral fracture
Vertebral fracture was ascertained by VFA according
to a standard set by GE Lunar Prodigy, Lunar Corp.,
Madison, USA; software version 12.20 [23]. VFA is a
semi-quantitative method developed for identification
of osteoporotic vertebral fractures based on measure-
ment of vertebral height, identifying the anterior, mid-
dle, and posterior heights of each vertebra. Depending
on their relative relations according to a given reference,
the software identifies three types of fractures: wedge,
biconcave, and compression, according to three degrees
of severity, ranging from mild through moderate to se-
vere [24,25] (Figure 2). The wedge fractures are charac-
terized by deformed structure of the anterior part of the
vertebrae, the biconcave of the middle part, and the
compression of the total vertebrae. In our dataset, only
1% of the deformities were identified as being mild, thus
persons with mild fracture were moved to the “moderate”
category.
Specially trained technicians did the scanning accord-
ing to the standardized protocol, and quality assessment
of the identified vertebrae was performed manually
afterwards. For precision analysis of the VFA, data from
a random sample of 50 participants was reanalyzed. The
mean intra-class correlation coefficient was 0.82, 0.79,
0.82, and 0.84 for anterior, middle, posterior, and average
height, respectively, all vertebrae considered [26]. At the
vertebrae with highest frequency of present deformity,
exemplified by 7th and 12th thoracic vertebrae, the mean
intra-class correlation coefficient was 0.86 (range 0.77
to 0.92).
Assessment of covariates
Prior to the examinations, all participants responded to
a self-administered questionnaire concerning health re-
lated topics including questions about past and current
smoking habits, cardiovascular disease (angina pectoris,
myocardial infarction, or cerebral stroke), and physical
activity. Women also reported use of systemic estrogens
(hormone therapy for menopausal symptoms). Use of
inhaled and systemic corticosteroids was defined from
self-report of brand names belonging to ATC groups
R03BA and R03AK, and H02AB, respectively. At the
physical examination, height and weight were measured
to the nearest centimeter and half-kilogram, respectively,
with subjects wearing light clothing and no shoes. BMD
of the total hip was measured in g/cm2 by the same GE
Lunar Prodigy DXA scanner used for the vertebral
morphometry.
Statistical analyses
Possible associations between presence of vertebral frac-
ture as exposure and pulmonary function measures as
outcome were examined using general linear models
Figure 1 Flowchart of the study.
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and ANCOVA). Pulmonary function was expressed as 1)
predicted percentages of FVC, FEV1, and FEV1/FVC values,
2) multiple adjusted FVC, FEV1, and FEV1/FVC values,
and 3) obstructive and restrictive ventilatory impairment.
Each vertebral fracture was classified according to
presence, number, severity, and location of fractures.
Presence of vertebral fracture was confirmed if at least
one fracture was present at any level of the vertebrae.
Airways restriction was defined as FVC and FEV1 less
than 80% of predicted values and FEV1/FVC ≥0.7. As
main criterion, obstruction was defined as FEV1/FVC <0.7,
with mild obstruction defined as FEV1% predicted ≥80%,moderate obstruction as FEV1% predicted <80% and ≥50%,
and severe obstruction defined as FEV1% predicted <50%.
Calculations of predicted values were based on the
equations published by Langhammer et al. [27] for a
Norwegian adult population, which are based on age
and current body height. Since reduced height due to
vertebral fractures leads to decreased predicted values of
spirometry, and accordingly increased % predicted values,
we repeated the analyses using previous height in 1994–95
instead of current height in a subsample (n = 2058).
In the multiple adjusted model, FVC, FEV1 and FEV1/
FVC ratio were controlled for age, smoking habits, weight,
current height, physical activity, use of corticosteroids
Figure 2 Diagram of a semiquantitative method for diagnosing osteoporotic vertebral fractures. The semiquantitative method was
developed for identification of osteoporotic vertebral fractures based on measurement of vertebral height, identifying the anterior, middle, and
posterior heights of each vertebra. Depending on their relative relations according to a given reference, three types of fractures are identified:
wedge, biconcave, and compression, according to three degrees of severity, ranging from mild through moderate to severe. The wedge fractures
are characterized by deformed structure of the anterior part of the vertebrae, the biconcave of the middle part, and the compression of the total
vertebrae. Reprinted from Lenchik et al. [25] with permission from the American Journal of Roentgenology.
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reported cardiovascular diseases (myocardial infarction,
cerebral stroke, or angina pectoris) and chronic lung
diseases (asthma or chronic bronchitis/emphysema/chronic
obstructive pulmonary disease (COPD)). Test for multicol-
linearity between independent variables did not reveal high
correlation between any of the covariates. As one could
expect, both women and men showed highest correl-
ation between height and weight (0.3-0.5, P < 0.001) and
between lung disease (CLD) and use of corticosteroids
(0.5-0.6, P < 0.001). Tolerance was high (>0.6).
Finally, we calculated age-adjusted and multiple adjusted
odds for experiencing airways restriction and obstruc-
tion in relation to prevalence of vertebral fracture.
Two-sided P values <0.05 were considered statistically
significant. All analyses were performed using IBM SPSS
Statistics, version 19.
Results
The study comprised 892 men and 1240 women be-
tween 55 and 87 years, with a mean age of 67.8 (SD 7.5)
years. Vertebral fracture was present in 121 (13.6%) men
and 161 (13.0%) women. As shown in Table 1, subjects
with vertebral fracture were older and had lower total
hip BMD than those without (P < 0.001). In addition,
women with vertebral fracture were shorter and weighed
less than women without fracture (P < 0.05). Corticoster-
oid use and pulmonary disease (men) and frequency ofcardiovascular disease (women) were higher in subjects
with fracture (P < 0.001). Men and women with vertebral
fracture had lower absolute FVC (P ≤ 0.014), FEV1
(P ≤ 0.001), and FEV1/FVC ratio (P ≤ 0.046) than those
with no fracture.Predicted FVC%, FEV1%, and FEV1/FVC% values
FVC% predicted and FEV1% predicted did not differ sig-
nificantly between subjects with and without fracture.
Men with vertebral fracture had lower FEV1/FVC% pre-
dicted than men with no vertebral fracture (P = 0.003)
(Table 2).
In men, FVC% predicted, FEV1% predicted, and FEV1/
FVC% predicted ratio values decreased as number of
vertebral fractures increased (P < 0.05) (Table 3). In women,
no such trend was found for FVC% predicted and FEV1%
predicted, whereas FEV1/FVC% predicted ratio was in-
versely related to number of vertebral fractures (P = 0.021).
Women and men with 4 or more fractures had signifi-
cantly lower FEV1% predicted than those without frac-
ture (P ≤ 0.05).
Neither FVC% predicted nor FEV1% predicted were
associated with fracture site (T4-T12 or L1-L4) (Table 4).
FEV1/FVC% predicted was significantly lower in men
and women with lumbar (L1-L4) fracture and in men
with thoracic (T4-T12) fracture, compared with men and
women with no fracture.
Table 1 Characteristics of the study population by gender and vertebral fracture










Age (years) 67.4 (7.6) 70.4 (7.5) <0.001 67.3 (7.1) 71.3 (7.6) <0.001
Body height (cm) 175.1 (6.5) 174.2 (6.9) 0.182 162.1 (6.1) 160.3 (7.1) 0.001
Body weight (kg) 83.9 (12.1) 82.9 (11.7) 0.371 71.0 (12.4) 68.8 (12.4) 0.039
Hip bone mineral density (BMD) (g/cm2)a 1.027 (0.142) 0.973 (0.161) <0.001 0.901 (0.130) 0.830 (0.115) <0.001
Smoking 0.491 0.421
Current 13.6% (105) 17.4% (21) 17.5% (189) 19.3% (31)
Past 61.6% (753) 57.0% (69) 41.5% (448) 36.0% (58)
Never 24.8% (191) 25.6% (31) 41.0% (443) 44.7% (72)
Physical inactivityb 20.4% (141) 17.4% (19) 0.661 19.7% (181) 18.8% (26) 0.947
Cardiovascular diseasec 22.6% (174) 24.0% (29) 0.733 10.1% (109) 15.5% (25) 0.038
Lung diseased 11.2% (86) 18.2% (22) 0.028 14.8% (160) 12.4% (20) 0.421
Hormone drugs for menopausee 7.7% (76) 4.6% (6) 0.193
Corticosteroid use 5.8% (45) 11.6% (14) 0.018 8.3% (90) 9.3% (15) 0.678
FVC (liter (SE)) 4.20 (0.81) 4.00 (0.86) 0.014 2.95 (0.56) 2.77 (0.64) <0.001
FEV1 (liter (SE)) 3.05 (0.70) 2.82 (0.79) 0.001 2.18 (0.48) 2.02 (0.55) <0.001
FEV1/FVC (% (SD)) 72.5 (8.7) 69.9 (10.5) 0.003 73.8 (7.4) 72.5 (8.4) 0.046
The Tromsø Study 2007-08.
Values are mean (SD) or % (n).
an = 860 men and 1152 women.
bn = 799 men and 1057 women.
cCerebral stroke, myocardial infarction, or angina pectoris.
dAsthma, chronic bronchitis, emphysema, or COPD.
en = 1112 women.
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FEV1% predicted, or FEV1/FVC % predicted, except in
men with severe fracture, who had lower FEV1/FVC %
predicted than men with no fracture (P = 0.004) (Table 5).
Multiple adjusted FVC, FEV1, and FEV1/FVC values
When FVC, FEV1, and FEV1/FVC values were adjusted for







FVC% predicteda 98.2 (17.4) 97.2 (17.6)
FEV1% predicted
a 88.9 (16.9) 85.6 (21.3)
FEV1/FVC% predicted
a 90.6 (10.8) 87.4 (13.0)
Adjustedb values (n = 665) (n = 105)
FVC (liter (SE)) 4.22 (0.024) 4.23 (0.062)
FEV1 (liter (SE)) 3.08 (0.021) 3.05 (0.054)
FEV1/FVC (SE) 0.73 (0.003) 0.72 (0.007)
The Tromsø Study 2007-08.
aEquation from Langhammer et al. [27].
bAdjusted for age, smoking habits, height, weight, physical inactivity, cardiovascular diwith prevalent vertebral fracture, number of fractures,
fracture site or severity.
Obstructive and restrictive ventilatory impairment
When pulmonary dysfunction was characterized accord-
ing to restrictive and obstructive ventilatory impairment,
age-adjusted analyses showed that women and men with
prevalent vertebral fracture had higher risk of severection
ry function (mean (SD) or (SE))
Women





0.522 101.2 (15.8) 102.2 (18.2) 0.475
0.055 93.0 (17.4) 93.3 (20.9) 0.842
0.003 92.0 (9.1) 90.6 (10.4) 0.083
(n = 800) (n = 104)
0.951 2.98 (0.015) 3.01 (0.043) 0.560
0.650 2.21 (0.013) 2.24 (0.037) 0.408
0.291 0.74 (0.002) 0.74 (0.007) 0.557
sease, lung disease, corticosteroids, hip BMD, hormones for menopause (women).
Table 3 Associations between number of vertebral fracture and lung function
Pulmonary function (mean (SD) or (SE))
Men Women
Number of vertebral fractures Number of vertebral fractures
0 (n=771) 1 (n=83) 2 (n=26) 3 (n=9) 4-6 (n=3) P trend 0 (n=1079) 1 (n=103) 2 (n=37) 3 (n=11) 4-6 (n=10) P trend
FVC% predicteda 98.2 (15.3) 97.9 (17.9) 99.5 (17.1) 90.0 (15.2) 80.1 (10.3) 0.047 101.2 (15.8) 102.6 (18.3) 101.7 (17.4) 107.6 (16.1) 94.1 (21.1) 0.137
FEV1% predicted
a 88.9 (16.9) 87.2 (20.2) 84.3 (24.9) 79.6 (22.7) 70.8 (12.3) 0.007 93.0 (17.4) 94.2 (20.5) 93.1 (20.5) 94.2 (24.0) 83.9 (23.3) 0.437
FEV1/FVC% predicted
a 90.6 (10.8) 88.8 (10.9) 83.2 (17.7) 87.2 (16.4) 87.8 (4.3) 0.002 92.0 (9.1) 91.2 (10.4) 91.1 (9.3) 86.0 (13.7) 88.0 (10.5) 0.021
Adjustedb values (n=665) (n=74) (n=22) (n=7) (n=2) (n=800) (n=65) (n=26) (n=5) (n=8)
FVC (liter (SE)) 4.22 (0.024) 4.22 (0.073) 4.29 (0.133) 4.18 (0.237) 4.10 (0.442) 0.982 2.99 (0.015) 3.09 (0.053) 2.90 (0.084) 2.89 (0.192) 2.75 (0.154) 0.321
FEV1 (liter (SE)) 3.08 (0.021) 3.07 (0.063) 2.94 (0.116) 3.24 (0.206) 3.12 (0.384) 0.747 2.21 (0.013) 2.32 (0.046) 2.15 (0.073) 2.04 (0.166) 2.08 (0.134) 0.476
FEV1/FVC (SE) 0.73 (0.003) 0.73 (0.009) 0.67 (0.016) 0.79 (0.028) 0.76 (0.053) 0.502 0.74 (0.002) 0.75 (0.008) 0.74 (0.013) 0.69 (0.029) 0.76 (0.023) 0.874
The Tromsø Study 2007-08.
aEquation from Langhammer et al. [27].



















Table 4 Associations between vertebral fracture and lung function according to fracture site














P T4-T12a P L1-L4a
FVC% predictedb 98.2 (15.3) 97.0 (17.5) 97.7 (18.1) 0.500 0.856 101.2 (15.8) 104.4 (17.4) 99.0 (18.7) 0.058 0.264
FEV1% predicted
b 88.9 (16.9) 85.7 (21.4) 85.3 (21.5) 0.120 0.219 93.0 (17.4) 95.8 (19.5) 89.8 (22.3) 0.145 0.154
FEV1/FVC% predicted
a 90.6 (10.8) 87.8 (13.6) 86.8 (11.8) 0.027 0.035 92.0 (9.1) 91.3 (9.6) 89.6 (11.4) 0.505 0.046
Adjustedc values (n = 665) (n = 74) (n = 31) (n = 800) (n = 60) (n = 44)
FVC (liter (SE)) 4.22 (0.024) 4.18 (0.073) 4.34 (0.113) 0.569 0.296 2.99 (0.015) 3.10 (0.055) 2.89 (0.066) 0.045 0.141
FEV1 (liter (SE)) 3.08 (0.021) 3.01 (0.063) 3.16 (0.098) 0.292 0.415 2.21 (0.013) 2.32 (0.048) 2.14 (0.057) 0.032 0.212
FEV1/FVC (SE) 0.73 (0.003) 0.72 (0.009) 0.73 (0.014) 0.240 0.857 0.74 (0.002) 0.75 (0.008) 0.74 (0.010) 0.405 0.960
The Tromsø Study 2007-08.
aVersus no fracture.
bEquation from Langhammer et al. [27].



















Table 5 Associations between vertebral fracture and lung function according to severity of fracture


















FVC% predictedb 98.2 (15.3) 96.8 (17.7) 97.7 (17.6) 0.479 0.837 101.2 (15.8) 103.4 (18.3) 101.0 (17.9) 0.238 0.896
FEV1% predicted
b 88.9 (16.9) 86.1 (20.5) 85.0 (22.5) 0.218 0.111 93.1 (17.4) 94.9 (20.7) 91.7 (21.0) 0.352 0.526
FEV1/FVC% predicted
a 90.6 (10.8) 88.5 (11.7) 86.2 (14.5) 0.134 0.004 92.0 (9.1) 91.1 (10.5) 90.1 (10.4) 0.441 0.078
Adjustedc values (n=665) (n=61) (n=44) (n=800) (n=56) (n=48)
FVC (liter (SE)) 4.22 (0.024) 4.20 (0.080) 4.26 (0.095) 0.827 0.714 2.99 (0.015) 3.10 (0.057) 2.90 (0.064) 0.056 0.209
FEV1 (liter (SE)) 3.08 (0.021) 3.02 (0.069) 3.10 (0.083) 0.441 0.847 2.21 (0.013) 2.31 (0.050) 2.16 (0.056) 0.054 0.373
FEV1/FVC (SE) 0.73 (0.003) 0.72 (0.010) 0.73 (0.012) 0.215 0.821 0.74 (0.002) 0.75 (0.009) 0.74 (0.010) 0.402 0.973
The Tromsø Study 2007-08.
aVersus no fracture.
bEquation from Langhammer et al. [27].
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tebral fracture, odds ratio (OR) 5.18 in women (P = 0.029)
and 2.72 in men (P = 0.003) (Table 6). However, multiple
adjustments resulted in non-significant ORs. Prevalent
vertebral fracture was not associated with mild or mod-
erate obstructive or restrictive ventilatory impairment
(results not shown).
In a model including a subsample of 859 men and 1199
women, current height was replaced by previous height.
Adjusting for previous height did not significantly alter
the results of the main model with current height.
Discussion
In this cross-sectional study, we found few differences
in predicted pulmonary values when comparing people
with and without prevalent vertebral fracture. We noted,
however, that in men, FVC% predicted, FEV1% predicted,
and FEV1/FVC% predicted ratio decreased as the num-
ber of vertebral fractures increased. Furthermore, women
and men with 4 or more fractures had significantly lower
FVC% predicted than those without fracture. Multiple
adjusted FVC, FEV1, and FEV1/FVC values were not
significantly associated with vertebral fracture. Finally,
presence of a vertebral fracture was not associated with
mild, moderate, or severe obstructive or restrictive ven-
tilatory impairment.
Previous studies have shown an association between
vertebral fracture and reduced FVC% predicted and
FEV1% predicted [14,16,17], which we did not replicate
in our study. However, in contrast to our study, in which
calculation of predicted values is based on current height,
two of the previous studies based the calculations of
predicted values on arm span [14] or recalled height
[17]. When Schlaich et al. [17] used current height
instead of recalled height, the associations became
non-significant, consistent with our results.
Vertebral fracture may cause both height loss and im-
paired pulmonary function, thus adjustment for current
height may bias the association toward null. Larger than
normal height reduction, frequently presented in subjects
with vertebral fracture, may overestimate lung function
(in % of predicted) with adjustments for current height
instead of previous height or arm-span [28]. We therefore
performed analyses based on previous height measuresTable 6 Odds for severe obstructive ventilatory impairment i
Severe obstructive pulmonary di
Vertebral fracture Men
n (%) Model 1a OR (95% CI) Model 2b OR
No vertebral fracture 17 (2.2%)
Vertebral fracture 7 (5.8%) 2.72 (1.11-6.71) 1.41 (0.36-
The Tromsø Study 2007-08.
aModel 1: Unadjusted.
bModel 2: Adjusted for smoking habits, weight, physical inactivity, cardiovascular difrom 14 years earlier in a subsample of the population,
but we still found no associations between pulmonary
function and vertebral fracture, as opposed to the associa-
tions found by Leech et al. [14] and Schlaich et al. [17].
In accordance with Leech et al. [14], who estimated that
for each additional vertebral fracture, FVC% predicted was
reduced by 9%, we found that FVC% predicted, as well
as FEV1% predicted and FEV1/FVC% predicted ratio,
decreased as number of vertebral fractures increased,
although in men only. Unfortunately, kyphosis was not
measured in our study.
Recently, Horie et al. [29] reported reduced FVC, FEV1
and FVC% predicted with increased lumbar lordosis angle,
but not thoracic kyphosis angle, in elderly women. In our
study, we found significantly lower FEV1/FVC% predicted
in women and men with lumbar vertebral fracture than
in those without fracture. This may seem surprising, as
the lumbar vertebrae are not part of the rib cage. How-
ever, according to Horie et al. [29] there may be a reason-
able theory behind these findings. The lumbar vertebrae
are attached to the diaphragm, which main function is to
contract and expand the lungs during inspiration. Lumbar
vertebral fracture may lead to reduced constriction effi-
ciency of the diaphragm and thus decrease the expansion
of the lungs [29]. It should be noted that analyses of sever-
ity and number of fractures in men had low power due a
small number of fractures.
There could be several explanations for the disparity
between our study and previous studies, which are small
patient studies, primarily including women [11,14,16,17].
Furthermore, some of the previous studies did not adjust
for smoking status [14,17], which could be a confounding
factor, due to the strong effect on lung function. Previous
studies have identified vertebral fractures radiographically
[14,16,17], whereas VFA with semi-quantitative analyses
was used in our study. Recent developments in DXA tech-
nology now allow population-based identification of preva-
lent vertebral fracture using DXA densitometers [30].
Although spine radiographs are generally considered to
be the gold standard for the diagnosis of vertebral frac-
tures [31,32], the morphometric method used in our
study is recognized to be easy and precise and with low
radiation exposure [24,33,34]. The vertebral fracture
assessment method has been used in many populationn relation to vertebral fracture
sease (FEV1% predicted <50% and FEV1/FVC <70%)
Women
(95% CI) n (%) Model 1a OR (95% CI) Model 2b OR (95% CI)
8 (0.7%)
5.50) 6 (3.7%) 5.18 (1.77-15.14) 2.65 (0.53-13.14)
sease, lung disease, corticosteroids, hip BMD.
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to spinal radiographs in the ability to diagnose grade 2
and 3 vertebral fracture [8,30]. Still, different methods
may produce disparities.
The multiple regression covariates are chosen based
on previous research and possible confounding effects.
As expected, age was the most important covariate, and
the other covariates provided only minor changes to the
results. There are few reports of the association between
physical activity and vertebral fracture, but most studies
show a reduced risk of vertebral fracture with higher
physical activity levels [35-39]. Physical activity is also
related to lung function, as COPD has been shown to
limit physical capacity [40], although it is generally be-
lieved that ventilatory capacity does not limit perform-
ance in healthy humans. In our study, physical activity
was not related to pulmonary function, probably because
most subjects were healthy. Adjusting for cardiovascular
(CVD) and lung disease (CLD) is based on the assump-
tion that for instance CVD could be a confounder in the
relationship between lung function and vertebral fracture.
When BMD is measured at the hip, it has been shown
that relative risk of vertebral fractures increases 1.6 times
per SD [41]. In our study, men and women have similar
rates of fractures, although women have lower BMD in
the hip. This may indicate that fact that fracture risk is
also affected by many other factors, such as other skel-
etal mechanisms (bone architecture and geometry) [42].
Limitations of this study include the cross-sectional
design, which prevents us from determining any cause-
effect associations. We do not know how or when the
identified vertebral fractures occurred. Many vertebral
fractures are asymptomatic [43], others may be of mech-
anic origin or may have happened many years ago; all
are factors that may weaken the association between
prevalent vertebral fractures and pulmonary function.
Moreover, we hypothesized that the presence of a verte-
bral fracture imposes restrictions on the pulmonary
function, based on the assumption that the mechanisms
underlying an association involve spinal kyphosis, which
leads to decreased thoracic volume and disturbances in
the joint between the vertebral body and the rib and the
respiratory muscles [17,29]. Reversing the cause-effect
direction, some previous case–control studies have shown
that patients with COPD may be at higher risk for osteo-
porosis and vertebral fractures [44], through mechanisms
such as inflammation [45], increased bone resorption [46]
or steroid use [47]. Osteoporosis may in turn increase the
risk of vertebral fracture and further exacerbate pulmon-
ary dysfunction, creating a negative circle.
Our observational design opens for selection bias.
Although the Tromsø Study has a high participation rate,
individuals with poor health may be under-represented.
In the context of a previous Tromsø Study [48], a surveyamong non-participants showed that the responders
were less likely to be smokers and to have respiratory
symptoms, but more likely to be married, than the non-
responders, whereas age, body mass index, and blood
pressure did not differ. Although differences between
participants and non-participants should be a matter of
concern to the validity, we believe the association between
vertebral fracture and pulmonary function most likely did
not differ between the participants in our study and eli-
gible persons who did not attend. For further assessment
of the impact of vertebral fracture on pulmonary function,
longitudinal studies are warranted.
Conclusion
Although we found an inverse association between some
pulmonary markers and number of vertebral fractures, we
conclude that this study identified limited indications of any
clinically relevant associations between vertebral fracture
and ventilatory impairment in elderly men and women.
Abbreviations
ANCOVA: Analysis of covariance; ANOVA: Analysis of variance; BMD: Bone
mineral density; COPD: Chronic obstructive pulmonary disease; DXA: Dual X-ray;
FEV1: Forced expiratory volume in one second; FVC: Forced vital capacity;
OR: Odds ratio; VFA: Vertebral fracture assessment.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
NE made substantial contributions to the conception of the study. BM, SW
and HM participated in the design and interpretation of data; BM, MRT, HM
and MJR participated in the analysis and interpretation of data. SW did the
DEXA scans and carried out the vertebral fracture analyses. BM performed
the statistical analyses and drafted the manuscript. All authors helped
revising the manuscript and all approved the final version to be published.
Acknowledgements
This work was funded by grants from the Northern Norwegian Health
Authorities. We thank the Tromsø Study for providing data.
Author details
1Department of Community Medicine, University of Tromsø, Tromsø, Norway.
2Regional Centre for Sport, Exercise and Health, Faculty of Health Sciences,
University of Tromsø, Tromsø, Norway. 3General Practice Research Unit,
Department of Community Medicine, University of Tromsø, Tromsø, Norway.
4Department of Occupational and Environmental Medicine, University
Hospital of North Norway, Tromsø, Norway. 5University Hospital of North
Norway, Tromsø, Norway. 6Department of Health and Care Sciences,
University of Tromsø, Tromsø, Norway.
Received: 14 March 2013 Accepted: 28 October 2013
Published: 29 October 2013
References
1. Ahmed LA, Schirmer H, Bjørnerem A, Emaus N, Jørgensen L, Størmer J,
Joakimsen RM: The gender- and age-specific 10-year and lifetime absolute
fracture risk in Tromsø Norway. Eur J Epidemiol 2009, 24(8):441–448.
2. Johnell O, Kanis J: Epidemiology of osteoporotic fractures. Osteoporos Int
2005, 16(Suppl 2):S3–S7.
3. Cummings SR, Melton LJ: Epidemiology and outcomes of osteoporotic
fractures. Lancet 2002, 359(9319):1761–1767.
4. Lofthus CM, Osnes EK, Falch JA, Kaastad TS, Kristiansen IS, Nordsletten L,
Stensvold I, Meyer HE: Epidemiology of hip fractures in Oslo Norway.
Bone 2001, 29(5):413–418.
Morseth et al. BMC Geriatrics 2013, 13:116 Page 11 of 11
http://www.biomedcentral.com/1471-2318/13/1165. O'Neill TW, Roy DK: How many people develop fractures with what
outcome? Best Pract Res Clin Rheumatol 2005, 19(6):879–895.
6. Johnell O, Kanis JA: An estimate of the worldwide prevalence and
disability associated with osteoporotic fractures. Osteoporos Int 2006,
17(12):1726–1733.
7. Kanis JA, Johnell O, Oden A, Borgstrom F, Zethraeus N, De Laet C, Jonsson B:
The risk and burden of vertebral fractures in Sweden. Osteoporos Int 2004,
15(1):20–26.
8. Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA: Mortality
after all major types of osteoporotic fracture in men and women: an
observational study. Lancet 1999, 353(9156):878–882.
9. Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C,
De Laet C, Jonsson B: Mortality after osteoporotic fractures. Osteoporos Int
2004, 15(1):38–42.
10. Iacovino JR: Mortality outcomes after osteoporotic fractures in men and
women. J Insur Med 2001, 33(4):316–320.
11. Harrison RA, Siminoski K, Vethanayagam D, Majumdar SR: Osteoporosis-
related kyphosis and impairments in pulmonary function: a systematic
review. J Bone Miner Res 2007, 22(3):447–457.
12. Yang HL, Zhao L, Liu J, Sanford CG Jr, Chen L, Tang T, Ebraheim NA:
Changes of pulmonary function for patients with osteoporotic vertebral
compression fractures after kyphoplasty. J Spinal Disord Tech 2007,
20:221–225. United States.
13. Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Licata A,
Benhamou L, Geusens P, Flowers K, et al: Risk of new vertebral fracture in
the year following a fracture. JAMA 2001, 285(3):320–323.
14. Leech JA, Dulberg C, Kellie S, Pattee L, Gay J: Relationship of lung function to
severity of osteoporosis in women. Am Rev Respir Dis 1990, 141(1):68–71.
15. Culham EG, Jimenez HA, King CE: Thoracic kyphosis, rib mobility, and lung
volumes in normal women and women with osteoporosis. Spine (Phila Pa
1976) 1994, 19(11):1250–1255.
16. Lombardi I Jr, Oliveira LM, Mayer AF, Jardim JR, Natour J: Evaluation of
pulmonary function and quality of life in women with osteoporosis.
Osteoporos Int 2005, 16(10):1247–1253.
17. Schlaich C, Minne HW, Bruckner T, Wagner G, Gebest HJ, Grunze M, Ziegler R,
Leidig-Bruckner G: Reduced pulmonary function in patients with spinal
osteoporotic fractures. Osteoporos Int 1998, 8(3):261–267.
18. Wilsgaard T, Jacobsen BK, Mathiesen EB, Njølstad I: Weight loss and
mortality: a gender-specific analysis of the Tromsø study. Gend Med 2009,
6(4):575–586.
19. Eggen AE, Mathiesen EB, Wilsgaard T, Jacobsen BK, Njolstad I: The sixth
survey of the Tromso Study (Tromso 6) in 2007–08: collaborative
research in the interface between clinical medicine and epidemiology:
study objectives, design, data collection procedures, and attendance in
a multipurpose population-based health survey. Scand J Public Health
2013, 41(1):65–80.
20. Melbye H, Amundsen K, Brox J, Eggen AE: The Association Between
Self-Reported Symptoms of Recent Airway Infection and CRP Values in a
General Population : The Tromso Study: Tromso 6. Inflammation 2012,
35(3):1015–1022.
21. American Thoracic Society: Standardization of Spirometry, 1994 Update.
American Thoracic Society. Am J Respir Crit Care Med 1995, 152(3):1107–1136.
22. Medbø A, Melbye H: Lung function testing in the elderly–can we still use
FEV1/FVC < 70% as a criterion of COPD? Respir Med 2007, 101(6):1097–1105.
23. Kim N, Rowe BH, Raymond G, Jen H, Colman I, Jackson SA, Siminoski KG,
Chahal AM, Folk D, Majumdar SR: Underreporting of vertebral fractures on
routine chest radiography. AJR Am J Roentgenol 2004, 182(2):297–300.
24. El Maghraoui A, Roux C: DXA scanning in clinical practice. QJM 2008,
101(8):605–617.
25. Lenchik L, Rogers LF, Delmas PD, Genant HK: Diagnosis of osteoporotic
vertebral fractures: importance of recognition and description by
radiologists. AJR Am J Roentgenol 2004, 183(4):949–958.
26. Waterloo S, Ahmed LA, Center JR, Eisman JA, Morseth B, Nguyen ND,
Nguyen T, Sogaard AJ, Emaus N: Prevalence of vertebral fractures in women
and men in the population-based Tromso Study. BMC Musculoskelet Disord
2012, 13:3.
27. Langhammer A, Johnsen R, Gulsvik A, Holmen TL, Bjermer L: Forced
spirometry reference values for Norwegian adults: the Bronchial
Obstruction in Nord-Trondelag Study. Eur Respir J 2001, 18(5):770–779.28. Kjensli A, Ryg M, Falch JA, Armbrecht G, Diep LM, Eriksen EF, Ellingsen I:
Does body height reduction influence interpretation of lung function in
COPD patients? Eur Respir J 2010, 36(3):540–548.
29. Horie J, Murata S, Inoue Y, Nakamura S, Maeda Y, Matsumoto Y, Sannomiya T,
Horikawa E: A Study of the Influence of the Pulmonary Function on the
Angles of Thoracic Kyphosis and Lumbar Lordosis in Community-Dwelling
Elderly Women. J Phys Ther Sci 2009, 21(2):169–172.
30. Ho-Pham LT, Nguyen ND, Vu BQ, Pham HN, Nguyen TV: Prevalence and
risk factors of radiographic vertebral fracture in postmenopausal
Vietnamese women. Bone 2009, 45(2):213–217.
31. Diacinti D, Guglielmi G: Vertebral morphometry. Radiol Clin North Am 2010,
48(3):561–575.
32. Middleton ET, Gardiner ED, Steel SA: Which women should be selected for
vertebral fracture assessment? Comparing different methods of
targeting VFA. Calcif Tissue Int 2009, 85(3):203–210.
33. Ensrud KE, Schousboe JT: Clinical practice Vertebral fractures. N Engl J Med
2011, 364(17):1634–1642.
34. Grigoryan M, Guermazi A, Roemer FW, Delmas PD, Genant HK: Recognizing
and reporting osteoporotic vertebral fractures. Eur Spine J 2003,
12(Suppl 2):S104–S112.
35. Gregg EW, Pereira MA, Caspersen CJ: Physical activity, falls, and fractures
among older adults: a review of the epidemiologic evidence. J Am Geriatr
Soc 2000, 48(8):883–893.
36. Gregg EW, Cauley JA, Seeley DG, Ensrud KE, Bauer DC: Physical activity and
osteoporotic fracture risk in older women Study of Osteoporotic
Fractures Research Group. Ann Intern Med 1998, 129(2):81–88.
37. Silman AJ, O'Neill TW, Cooper C, Kanis J, Felsenberg D: Influence of
physical activity on vertebral deformity in men and women: results from
the European Vertebral Osteoporosis Study. J Bone Miner Res 1997,
12(5):813–819.
38. Chan HH, Lau EM, Woo J, Lin F, Sham A, Leung PC: Dietary calcium intake,
physical activity and the risk of vertebral fracture in Chinese. Osteoporos
Int 1996, 6(3):228–232.
39. Greendale GA, Barrett-Connor E, Edelstein S, Ingles S, Haile R: Lifetime
leisure exercise and osteoporosis The Rancho Bernardo study. Am J
Epidemiol 1995, 141(10):951–959.
40. Aliverti A, Macklem PT: How and why exercise is impaired in COPD.
Respiration 2001, 68(3):229–239.
41. Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P, Eisman JA,
Fujiwara S, Kroger H, Mellstrom D, et al: Predictive value of BMD for hip
and other fractures. J Bone Miner Res 2005, 20(7):1185–1194.
42. Wehren LE, Magaziner J: Hip fracture: risk factors and outcomes.
Curr Osteoporos Rep 2003, 1(2):78–85.
43. Delmas PD, Van Langerijt LD, Watts NB, Eastell R, Genant H, Grauer A, Cahall DL:
Underdiagnosis of vertebral fractures is a worldwide problem: The IMPACT
study. J Bone Miner Res 2005, 20(4):557–563.
44. Papaioannou A, Parkinson W, Ferko N, Probyn L, Ioannidis G, Jurriaans E,
Cox G, Cook RJ, Kumbhare D, Adachi JD: Prevalence of vertebral fractures
among patients with chronic obstructive pulmonary disease in Canada.
Osteoporos Int 2003, 14(11):913–917.
45. Kjensli A, Mowinckel P, Ryg MS, Falch JA: Low bone mineral density is
related to severity of chronic obstructive pulmonary disease. Bone 2007,
40(2):493–497.
46. Dimai HP, Domej W, Leb G, Lau KH: Bone loss in patients with untreated
chronic obstructive pulmonary disease is mediated by an increase in
bone resorption associated with hypercapnia. J Bone Miner Res 2001,
16(11):2132–2141.
47. Langhammer A, Forsmo S, Syversen U: Long-term therapy in COPD: any
evidence of adverse effect on bone? Int J Chron Obstruct Pulmon Dis 2009,
4:365–380.
48. Jacobsen BK, Thelle DS: The Tromsø Heart Study: responders and
non-responders to a health questionnaire, do they differ? Scand J Soc
Med 1988, 16(2):101–104.
doi:10.1186/1471-2318-13-116
Cite this article as: Morseth et al.: Cross-sectional associations between
prevalent vertebral fracture and pulmonary function in the sixth Tromsø
study. BMC Geriatrics 2013 13:116.
